nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—CYP3A4—bone cancer	0.741	1	CbGaD
Calcitriol—VDR—periosteum—bone cancer	0.0127	0.185	CbGeAlD
Calcitriol—VDR—vertebral column—bone cancer	0.0105	0.153	CbGeAlD
Calcitriol—VDR—leg—bone cancer	0.0101	0.148	CbGeAlD
Calcitriol—VDR—forelimb—bone cancer	0.0101	0.146	CbGeAlD
Calcitriol—VDR—hindlimb—bone cancer	0.00906	0.132	CbGeAlD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00866	0.11	CbGpPWpGaD
Calcitriol—VDR—appendage—bone cancer	0.00777	0.113	CbGeAlD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.0076	0.0967	CbGpPWpGaD
Calcitriol—VDR—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00683	0.0869	CbGpPWpGaD
Calcitriol—Apprehension—Cisplatin—bone cancer	0.00642	0.0589	CcSEcCtD
Calcitriol—Hypermagnesaemia—Epirubicin—bone cancer	0.00504	0.0463	CcSEcCtD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00468	0.0595	CbGpPWpGaD
Calcitriol—Hypermagnesaemia—Doxorubicin—bone cancer	0.00466	0.0428	CcSEcCtD
Calcitriol—Renal failure chronic—Cisplatin—bone cancer	0.00457	0.042	CcSEcCtD
Calcitriol—VDR—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00399	0.0508	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00392	0.0499	CbGpPWpGaD
Calcitriol—Haemolysis—Cisplatin—bone cancer	0.00387	0.0355	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP4V2—bone cancer	0.00373	0.0474	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—NR1I2—bone cancer	0.00359	0.0456	CbGpPWpGaD
Calcitriol—GC—spinal cord—bone cancer	0.00321	0.0466	CbGeAlD
Calcitriol—VDR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00284	0.0361	CbGpPWpGaD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00273	0.0348	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00229	0.0291	CbGpPWpGaD
Calcitriol—VDR—connective tissue—bone cancer	0.00222	0.0323	CbGeAlD
Calcitriol—Taste metallic—Methotrexate—bone cancer	0.00212	0.0195	CcSEcCtD
Calcitriol—Serum creatinine increased—Cisplatin—bone cancer	0.002	0.0184	CcSEcCtD
Calcitriol—Hyperphosphataemia—Epirubicin—bone cancer	0.00185	0.017	CcSEcCtD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00174	0.0221	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00171	0.0218	CbGpPWpGaD
Calcitriol—Hyperphosphataemia—Doxorubicin—bone cancer	0.00171	0.0157	CcSEcCtD
Calcitriol—VDR—tendon—bone cancer	0.00152	0.0222	CbGeAlD
Calcitriol—Rhinorrhoea—Cisplatin—bone cancer	0.00152	0.0139	CcSEcCtD
Calcitriol—Laboratory test abnormal—Epirubicin—bone cancer	0.00151	0.0139	CcSEcCtD
Calcitriol—VDR—Ovarian Infertility Genes—CDK4—bone cancer	0.00149	0.019	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00148	0.0188	CbGpPWpGaD
Calcitriol—VDR—bone marrow—bone cancer	0.00148	0.0215	CbGeAlD
Calcitriol—VDR—Generic Transcription Pathway—ZNF77—bone cancer	0.00145	0.0184	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00141	0.0179	CbGpPWpGaD
Calcitriol—Laboratory test abnormal—Doxorubicin—bone cancer	0.0014	0.0129	CcSEcCtD
Calcitriol—Paricalcitol—CYP3A4—bone cancer	0.00132	0.416	CrCbGaD
Calcitriol—Pain—Carboplatin—bone cancer	0.00128	0.0118	CcSEcCtD
Calcitriol—Body temperature increased—Carboplatin—bone cancer	0.00118	0.0109	CcSEcCtD
Calcitriol—Urine abnormality—Epirubicin—bone cancer	0.00114	0.0105	CcSEcCtD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00112	0.0143	CbGpPWpGaD
Calcitriol—Urine analysis abnormal—Epirubicin—bone cancer	0.00107	0.00987	CcSEcCtD
Calcitriol—Psoriasis—Methotrexate—bone cancer	0.00107	0.00987	CcSEcCtD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00106	0.0135	CbGpPWpGaD
Calcitriol—Ergocalciferol—CYP3A4—bone cancer	0.00106	0.332	CrCbGaD
Calcitriol—Urine abnormality—Doxorubicin—bone cancer	0.00106	0.0097	CcSEcCtD
Calcitriol—Serum creatinine increased—Epirubicin—bone cancer	0.00103	0.00943	CcSEcCtD
Calcitriol—Polyuria—Cisplatin—bone cancer	0.00102	0.00934	CcSEcCtD
Calcitriol—Psoriasis—Epirubicin—bone cancer	0.00101	0.00923	CcSEcCtD
Calcitriol—Urine analysis abnormal—Doxorubicin—bone cancer	0.000994	0.00913	CcSEcCtD
Calcitriol—Serum creatinine increased—Doxorubicin—bone cancer	0.00095	0.00873	CcSEcCtD
Calcitriol—Redness—Epirubicin—bone cancer	0.000936	0.0086	CcSEcCtD
Calcitriol—Psoriasis—Doxorubicin—bone cancer	0.00093	0.00854	CcSEcCtD
Calcitriol—Hypercalcaemia—Epirubicin—bone cancer	0.000909	0.00835	CcSEcCtD
Calcitriol—Blister—Epirubicin—bone cancer	0.000876	0.00805	CcSEcCtD
Calcitriol—Redness—Doxorubicin—bone cancer	0.000866	0.00795	CcSEcCtD
Calcitriol—Albuminuria—Epirubicin—bone cancer	0.000846	0.00777	CcSEcCtD
Calcitriol—Hypercalcaemia—Doxorubicin—bone cancer	0.000841	0.00773	CcSEcCtD
Calcitriol—GC—Metabolism—NDUFA12—bone cancer	0.000839	0.0107	CbGpPWpGaD
Calcitriol—Blood creatinine increased—Cisplatin—bone cancer	0.000837	0.00768	CcSEcCtD
Calcitriol—Dehydration—Cisplatin—bone cancer	0.00083	0.00763	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000813	0.0103	CbGpPWpGaD
Calcitriol—Blister—Doxorubicin—bone cancer	0.000811	0.00745	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000804	0.00739	CcSEcCtD
Calcitriol—Cholecalciferol—CYP3A4—bone cancer	0.000801	0.252	CrCbGaD
Calcitriol—Nasopharyngitis—Cisplatin—bone cancer	0.000799	0.00734	CcSEcCtD
Calcitriol—Albuminuria—Doxorubicin—bone cancer	0.000783	0.00719	CcSEcCtD
Calcitriol—Pancreatitis—Cisplatin—bone cancer	0.000757	0.00695	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP3A4—bone cancer	0.000747	0.00951	CbGpPWpGaD
Calcitriol—Neoplasm malignant—Epirubicin—bone cancer	0.00074	0.0068	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000737	0.00938	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—bone cancer	0.000727	0.00925	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000709	0.00902	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ZNF77—bone cancer	0.000697	0.00886	CbGpPWpGaD
Calcitriol—GC—Metabolism—NT5C3A—bone cancer	0.000695	0.00885	CbGpPWpGaD
Calcitriol—Neoplasm malignant—Doxorubicin—bone cancer	0.000685	0.00629	CcSEcCtD
Calcitriol—Nocturia—Epirubicin—bone cancer	0.000681	0.00626	CcSEcCtD
Calcitriol—Conjunctivitis—Cisplatin—bone cancer	0.000669	0.00614	CcSEcCtD
Calcitriol—Bone pain—Epirubicin—bone cancer	0.00066	0.00606	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—GSTP1—bone cancer	0.000639	0.00813	CbGpPWpGaD
Calcitriol—Phosphatase alkaline increased—Epirubicin—bone cancer	0.000632	0.0058	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTP1—bone cancer	0.00063	0.00802	CbGpPWpGaD
Calcitriol—Nocturia—Doxorubicin—bone cancer	0.00063	0.00579	CcSEcCtD
Calcitriol—Urine output increased—Methotrexate—bone cancer	0.00061	0.00561	CcSEcCtD
Calcitriol—Bone pain—Doxorubicin—bone cancer	0.00061	0.00561	CcSEcCtD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000607	0.00773	CbGpPWpGaD
Calcitriol—Blood urea increased—Epirubicin—bone cancer	0.000596	0.00548	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.000585	0.00537	CcSEcCtD
Calcitriol—Polyuria—Methotrexate—bone cancer	0.000558	0.00513	CcSEcCtD
Calcitriol—Arrhythmia—Cisplatin—bone cancer	0.000552	0.00507	CcSEcCtD
Calcitriol—Blood urea increased—Doxorubicin—bone cancer	0.000552	0.00507	CcSEcCtD
Calcitriol—Erythema—Cisplatin—bone cancer	0.000538	0.00494	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000527	0.00484	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NR1I2—bone cancer	0.00049	0.00623	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000488	0.00448	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000484	0.00615	CbGpPWpGaD
Calcitriol—Dermatitis bullous—Epirubicin—bone cancer	0.00048	0.00441	CcSEcCtD
Calcitriol—Convulsion—Cisplatin—bone cancer	0.000466	0.00428	CcSEcCtD
Calcitriol—Pain in extremity—Epirubicin—bone cancer	0.000459	0.00421	CcSEcCtD
Calcitriol—Myalgia—Cisplatin—bone cancer	0.000458	0.00421	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—bone cancer	0.000458	0.00582	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000457	0.00581	CbGpPWpGaD
Calcitriol—Anxiety—Cisplatin—bone cancer	0.000456	0.00419	CcSEcCtD
Calcitriol—Discomfort—Cisplatin—bone cancer	0.000452	0.00416	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—NDUFA12—bone cancer	0.000448	0.0057	CbGpPWpGaD
Calcitriol—Dermatitis bullous—Doxorubicin—bone cancer	0.000444	0.00408	CcSEcCtD
Calcitriol—Anaphylactic shock—Cisplatin—bone cancer	0.000439	0.00403	CcSEcCtD
Calcitriol—Blood creatinine increased—Epirubicin—bone cancer	0.00043	0.00395	CcSEcCtD
Calcitriol—Dehydration—Epirubicin—bone cancer	0.000426	0.00392	CcSEcCtD
Calcitriol—Skin disorder—Cisplatin—bone cancer	0.000426	0.00392	CcSEcCtD
Calcitriol—Pain in extremity—Doxorubicin—bone cancer	0.000424	0.0039	CcSEcCtD
Calcitriol—Abdominal pain upper—Epirubicin—bone cancer	0.000419	0.00385	CcSEcCtD
Calcitriol—Anorexia—Cisplatin—bone cancer	0.000418	0.00384	CcSEcCtD
Calcitriol—Pancreatitis—Methotrexate—bone cancer	0.000415	0.00381	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000413	0.00379	CcSEcCtD
Calcitriol—Nasopharyngitis—Epirubicin—bone cancer	0.00041	0.00377	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.0004	0.00367	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—RB1—bone cancer	0.000398	0.00506	CbGpPWpGaD
Calcitriol—Blood creatinine increased—Doxorubicin—bone cancer	0.000398	0.00365	CcSEcCtD
Calcitriol—Dehydration—Doxorubicin—bone cancer	0.000395	0.00362	CcSEcCtD
Calcitriol—Pancreatitis—Epirubicin—bone cancer	0.000389	0.00357	CcSEcCtD
Calcitriol—Abdominal pain upper—Doxorubicin—bone cancer	0.000388	0.00356	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000382	0.00351	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MMP2—bone cancer	0.000382	0.00486	CbGpPWpGaD
Calcitriol—Decreased appetite—Cisplatin—bone cancer	0.000382	0.0035	CcSEcCtD
Calcitriol—Nasopharyngitis—Doxorubicin—bone cancer	0.000379	0.00349	CcSEcCtD
Calcitriol—Drowsiness—Methotrexate—bone cancer	0.000378	0.00347	CcSEcCtD
Calcitriol—Pain—Cisplatin—bone cancer	0.000375	0.00345	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—NT5C3A—bone cancer	0.000371	0.00472	CbGpPWpGaD
Calcitriol—Conjunctivitis—Methotrexate—bone cancer	0.000367	0.00337	CcSEcCtD
Calcitriol—Pancreatitis—Doxorubicin—bone cancer	0.00036	0.0033	CcSEcCtD
Calcitriol—Weight decreased—Epirubicin—bone cancer	0.000359	0.00329	CcSEcCtD
Calcitriol—Drowsiness—Epirubicin—bone cancer	0.000353	0.00325	CcSEcCtD
Calcitriol—Body temperature increased—Cisplatin—bone cancer	0.000347	0.00319	CcSEcCtD
Calcitriol—Conjunctivitis—Epirubicin—bone cancer	0.000344	0.00316	CcSEcCtD
Calcitriol—Urinary tract infection—Epirubicin—bone cancer	0.000344	0.00316	CcSEcCtD
Calcitriol—Haemoglobin—Methotrexate—bone cancer	0.000341	0.00313	CcSEcCtD
Calcitriol—VDR—Gene Expression—FUS—bone cancer	0.00034	0.00433	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MDM2—bone cancer	0.000339	0.00432	CbGpPWpGaD
Calcitriol—Haemorrhage—Methotrexate—bone cancer	0.000339	0.00311	CcSEcCtD
Calcitriol—Weight decreased—Doxorubicin—bone cancer	0.000332	0.00305	CcSEcCtD
Calcitriol—Drowsiness—Doxorubicin—bone cancer	0.000327	0.003	CcSEcCtD
Calcitriol—Hypersensitivity—Cisplatin—bone cancer	0.000323	0.00297	CcSEcCtD
Calcitriol—Erythema multiforme—Methotrexate—bone cancer	0.000321	0.00294	CcSEcCtD
Calcitriol—Haemoglobin—Epirubicin—bone cancer	0.000319	0.00293	CcSEcCtD
Calcitriol—Urinary tract infection—Doxorubicin—bone cancer	0.000318	0.00292	CcSEcCtD
Calcitriol—Conjunctivitis—Doxorubicin—bone cancer	0.000318	0.00292	CcSEcCtD
Calcitriol—Haemorrhage—Epirubicin—bone cancer	0.000317	0.00291	CcSEcCtD
Calcitriol—Asthenia—Cisplatin—bone cancer	0.000315	0.00289	CcSEcCtD
Calcitriol—GC—Metabolism—ENO2—bone cancer	0.000305	0.00387	CbGpPWpGaD
Calcitriol—Diarrhoea—Cisplatin—bone cancer	0.0003	0.00276	CcSEcCtD
Calcitriol—Erythema multiforme—Epirubicin—bone cancer	0.0003	0.00276	CcSEcCtD
Calcitriol—Erythema—Methotrexate—bone cancer	0.000295	0.00271	CcSEcCtD
Calcitriol—Haemoglobin—Doxorubicin—bone cancer	0.000295	0.00271	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—JUN—bone cancer	0.000295	0.00375	CbGpPWpGaD
Calcitriol—Haemorrhage—Doxorubicin—bone cancer	0.000294	0.0027	CcSEcCtD
Calcitriol—Dysgeusia—Methotrexate—bone cancer	0.000289	0.00265	CcSEcCtD
Calcitriol—Arrhythmia—Epirubicin—bone cancer	0.000283	0.0026	CcSEcCtD
Calcitriol—GC—Metabolism—DHFR—bone cancer	0.000283	0.00359	CbGpPWpGaD
Calcitriol—Vomiting—Cisplatin—bone cancer	0.000279	0.00256	CcSEcCtD
Calcitriol—Erythema multiforme—Doxorubicin—bone cancer	0.000278	0.00255	CcSEcCtD
Calcitriol—Rash—Cisplatin—bone cancer	0.000277	0.00254	CcSEcCtD
Calcitriol—Dermatitis—Cisplatin—bone cancer	0.000276	0.00254	CcSEcCtD
Calcitriol—Erythema—Epirubicin—bone cancer	0.000276	0.00254	CcSEcCtD
Calcitriol—Dysgeusia—Epirubicin—bone cancer	0.00027	0.00248	CcSEcCtD
Calcitriol—GC—Metabolism—GNA11—bone cancer	0.000264	0.00336	CbGpPWpGaD
Calcitriol—Arrhythmia—Doxorubicin—bone cancer	0.000262	0.00241	CcSEcCtD
Calcitriol—Nausea—Cisplatin—bone cancer	0.000261	0.00239	CcSEcCtD
Calcitriol—Convulsion—Methotrexate—bone cancer	0.000256	0.00235	CcSEcCtD
Calcitriol—Erythema—Doxorubicin—bone cancer	0.000256	0.00235	CcSEcCtD
Calcitriol—Agitation—Epirubicin—bone cancer	0.000254	0.00233	CcSEcCtD
Calcitriol—Myalgia—Methotrexate—bone cancer	0.000251	0.00231	CcSEcCtD
Calcitriol—Chest pain—Methotrexate—bone cancer	0.000251	0.00231	CcSEcCtD
Calcitriol—Dysgeusia—Doxorubicin—bone cancer	0.00025	0.0023	CcSEcCtD
Calcitriol—Discomfort—Methotrexate—bone cancer	0.000248	0.00228	CcSEcCtD
Calcitriol—Anaphylactic shock—Methotrexate—bone cancer	0.000241	0.00221	CcSEcCtD
Calcitriol—GC—Metabolism—CYP3A4—bone cancer	0.000239	0.00305	CbGpPWpGaD
Calcitriol—Convulsion—Epirubicin—bone cancer	0.000239	0.0022	CcSEcCtD
Calcitriol—Hypertension—Epirubicin—bone cancer	0.000238	0.00219	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000238	0.00303	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NR1I2—bone cancer	0.000236	0.003	CbGpPWpGaD
Calcitriol—Chest pain—Epirubicin—bone cancer	0.000235	0.00216	CcSEcCtD
Calcitriol—Myalgia—Epirubicin—bone cancer	0.000235	0.00216	CcSEcCtD
Calcitriol—Agitation—Doxorubicin—bone cancer	0.000235	0.00216	CcSEcCtD
Calcitriol—Anxiety—Epirubicin—bone cancer	0.000234	0.00215	CcSEcCtD
Calcitriol—Skin disorder—Methotrexate—bone cancer	0.000234	0.00215	CcSEcCtD
Calcitriol—Discomfort—Epirubicin—bone cancer	0.000232	0.00213	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—EGFR—bone cancer	0.000232	0.00295	CbGpPWpGaD
Calcitriol—Dry mouth—Epirubicin—bone cancer	0.00023	0.00211	CcSEcCtD
Calcitriol—Anorexia—Methotrexate—bone cancer	0.00023	0.00211	CcSEcCtD
Calcitriol—Anaphylactic shock—Epirubicin—bone cancer	0.000225	0.00207	CcSEcCtD
Calcitriol—Convulsion—Doxorubicin—bone cancer	0.000221	0.00203	CcSEcCtD
Calcitriol—Hypertension—Doxorubicin—bone cancer	0.000221	0.00203	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000219	0.00202	CcSEcCtD
Calcitriol—Skin disorder—Epirubicin—bone cancer	0.000219	0.00201	CcSEcCtD
Calcitriol—Insomnia—Methotrexate—bone cancer	0.000218	0.002	CcSEcCtD
Calcitriol—Chest pain—Doxorubicin—bone cancer	0.000218	0.002	CcSEcCtD
Calcitriol—Myalgia—Doxorubicin—bone cancer	0.000218	0.002	CcSEcCtD
Calcitriol—Anxiety—Doxorubicin—bone cancer	0.000217	0.00199	CcSEcCtD
Calcitriol—Discomfort—Doxorubicin—bone cancer	0.000215	0.00197	CcSEcCtD
Calcitriol—Anorexia—Epirubicin—bone cancer	0.000215	0.00197	CcSEcCtD
Calcitriol—Somnolence—Methotrexate—bone cancer	0.000214	0.00197	CcSEcCtD
Calcitriol—Dry mouth—Doxorubicin—bone cancer	0.000213	0.00195	CcSEcCtD
Calcitriol—Decreased appetite—Methotrexate—bone cancer	0.000209	0.00192	CcSEcCtD
Calcitriol—Anaphylactic shock—Doxorubicin—bone cancer	0.000209	0.00192	CcSEcCtD
Calcitriol—Pain—Methotrexate—bone cancer	0.000206	0.00189	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000205	0.00189	CcSEcCtD
Calcitriol—GC—Metabolism—GSTP1—bone cancer	0.000205	0.0026	CbGpPWpGaD
Calcitriol—Insomnia—Epirubicin—bone cancer	0.000204	0.00187	CcSEcCtD
Calcitriol—Skin disorder—Doxorubicin—bone cancer	0.000203	0.00186	CcSEcCtD
Calcitriol—Somnolence—Epirubicin—bone cancer	0.0002	0.00184	CcSEcCtD
Calcitriol—Anorexia—Doxorubicin—bone cancer	0.000199	0.00183	CcSEcCtD
Calcitriol—Gastrointestinal pain—Methotrexate—bone cancer	0.000197	0.00181	CcSEcCtD
Calcitriol—Decreased appetite—Epirubicin—bone cancer	0.000196	0.0018	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—TP53—bone cancer	0.000195	0.00248	CbGpPWpGaD
Calcitriol—Constipation—Epirubicin—bone cancer	0.000193	0.00177	CcSEcCtD
Calcitriol—Pain—Epirubicin—bone cancer	0.000193	0.00177	CcSEcCtD
Calcitriol—Urticaria—Methotrexate—bone cancer	0.000191	0.00176	CcSEcCtD
Calcitriol—Abdominal pain—Methotrexate—bone cancer	0.00019	0.00175	CcSEcCtD
Calcitriol—Body temperature increased—Methotrexate—bone cancer	0.00019	0.00175	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00019	0.00175	CcSEcCtD
Calcitriol—Insomnia—Doxorubicin—bone cancer	0.000189	0.00173	CcSEcCtD
Calcitriol—Somnolence—Doxorubicin—bone cancer	0.000185	0.0017	CcSEcCtD
Calcitriol—Gastrointestinal pain—Epirubicin—bone cancer	0.000184	0.00169	CcSEcCtD
Calcitriol—Decreased appetite—Doxorubicin—bone cancer	0.000181	0.00167	CcSEcCtD
Calcitriol—Urticaria—Epirubicin—bone cancer	0.000179	0.00164	CcSEcCtD
Calcitriol—Constipation—Doxorubicin—bone cancer	0.000178	0.00164	CcSEcCtD
Calcitriol—Pain—Doxorubicin—bone cancer	0.000178	0.00164	CcSEcCtD
Calcitriol—Abdominal pain—Epirubicin—bone cancer	0.000178	0.00164	CcSEcCtD
Calcitriol—Body temperature increased—Epirubicin—bone cancer	0.000178	0.00164	CcSEcCtD
Calcitriol—Hypersensitivity—Methotrexate—bone cancer	0.000177	0.00163	CcSEcCtD
Calcitriol—VDR—Gene Expression—EIF2S1—bone cancer	0.000174	0.00222	CbGpPWpGaD
Calcitriol—Asthenia—Methotrexate—bone cancer	0.000173	0.00159	CcSEcCtD
Calcitriol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000171	0.00157	CcSEcCtD
Calcitriol—Pruritus—Methotrexate—bone cancer	0.00017	0.00157	CcSEcCtD
Calcitriol—Hypersensitivity—Epirubicin—bone cancer	0.000166	0.00153	CcSEcCtD
Calcitriol—Urticaria—Doxorubicin—bone cancer	0.000166	0.00152	CcSEcCtD
Calcitriol—Abdominal pain—Doxorubicin—bone cancer	0.000165	0.00151	CcSEcCtD
Calcitriol—Body temperature increased—Doxorubicin—bone cancer	0.000165	0.00151	CcSEcCtD
Calcitriol—Diarrhoea—Methotrexate—bone cancer	0.000165	0.00151	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—ENO2—bone cancer	0.000163	0.00207	CbGpPWpGaD
Calcitriol—Asthenia—Epirubicin—bone cancer	0.000162	0.00149	CcSEcCtD
Calcitriol—Pruritus—Epirubicin—bone cancer	0.000159	0.00146	CcSEcCtD
Calcitriol—Diarrhoea—Epirubicin—bone cancer	0.000154	0.00142	CcSEcCtD
Calcitriol—Hypersensitivity—Doxorubicin—bone cancer	0.000154	0.00141	CcSEcCtD
Calcitriol—Vomiting—Methotrexate—bone cancer	0.000153	0.00141	CcSEcCtD
Calcitriol—Rash—Methotrexate—bone cancer	0.000152	0.00139	CcSEcCtD
Calcitriol—Dermatitis—Methotrexate—bone cancer	0.000152	0.00139	CcSEcCtD
Calcitriol—VDR—Gene Expression—EZH2—bone cancer	0.000151	0.00192	CbGpPWpGaD
Calcitriol—Headache—Methotrexate—bone cancer	0.000151	0.00139	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—DHFR—bone cancer	0.000151	0.00192	CbGpPWpGaD
Calcitriol—Asthenia—Doxorubicin—bone cancer	0.00015	0.00137	CcSEcCtD
Calcitriol—Pruritus—Doxorubicin—bone cancer	0.000148	0.00136	CcSEcCtD
Calcitriol—Vomiting—Epirubicin—bone cancer	0.000143	0.00132	CcSEcCtD
Calcitriol—Nausea—Methotrexate—bone cancer	0.000143	0.00131	CcSEcCtD
Calcitriol—Diarrhoea—Doxorubicin—bone cancer	0.000143	0.00131	CcSEcCtD
Calcitriol—Rash—Epirubicin—bone cancer	0.000142	0.00131	CcSEcCtD
Calcitriol—Dermatitis—Epirubicin—bone cancer	0.000142	0.0013	CcSEcCtD
Calcitriol—Headache—Epirubicin—bone cancer	0.000141	0.0013	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GNA11—bone cancer	0.000141	0.00179	CbGpPWpGaD
Calcitriol—Nausea—Epirubicin—bone cancer	0.000134	0.00123	CcSEcCtD
Calcitriol—Vomiting—Doxorubicin—bone cancer	0.000133	0.00122	CcSEcCtD
Calcitriol—Rash—Doxorubicin—bone cancer	0.000131	0.00121	CcSEcCtD
Calcitriol—Dermatitis—Doxorubicin—bone cancer	0.000131	0.00121	CcSEcCtD
Calcitriol—Headache—Doxorubicin—bone cancer	0.000131	0.0012	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000128	0.00163	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP3A4—bone cancer	0.000128	0.00163	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000127	0.00162	CbGpPWpGaD
Calcitriol—Nausea—Doxorubicin—bone cancer	0.000124	0.00114	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—GSTP1—bone cancer	0.000109	0.00139	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTGS2—bone cancer	0.000106	0.00135	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTP1—bone cancer	8.3e-05	0.00106	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	8.18e-05	0.00104	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NDUFA12—bone cancer	5.81e-05	0.00074	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS2—bone cancer	5.66e-05	0.000721	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NT5C3A—bone cancer	4.82e-05	0.000613	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ENO2—bone cancer	2.11e-05	0.000268	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—DHFR—bone cancer	1.96e-05	0.000249	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GNA11—bone cancer	1.83e-05	0.000233	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTP1—bone cancer	1.42e-05	0.00018	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS2—bone cancer	7.35e-06	9.35e-05	CbGpPWpGaD
